Role of P14 and MGMT Gene Methylation in Hepatocellular Carcinomas: a Meta-analysis |
Li, Cheng-Cheng
(Department of Public Health, Qingdao University Medical College)
Yu, Zhuang (Department of Oncology, the Affiliated Hospital of Medical College Qingdao University) Cui, Lian-Hua (Department of Public Health, Qingdao University Medical College) Piao, Jin-Mei (Department of Public Health, Qingdao University Medical College) Liu, Meng (Department of Public Health, Qingdao University Medical College) |
1 | Ael-R Z, Nassar AA, El-Din EMN, et al (2013). Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation. Asian Pac J Cancer Prev, 14, 6721-6. 과학기술학회마을 DOI ScienceOn |
2 | Anzola M, Cuevas N, Lopez-Martinez M, et al (2004). P14ARF gene alterations in human hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 16, 19-26. DOI |
3 | Citron M, Decker R, Chen S, et al (1991). O6-methylguanine- DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary. Cancer Res, 51, 4131-4. |
4 | Esteller M (2006). Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer, 94, 179-83. DOI ScienceOn |
5 | Esteller M, Hamilton SR, Burger PC, et al (1999). Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res, 59, 793-7. |
6 | Fleiss JL (1993). The statistical basis of meta-analysis. Stat Methods Med Res, 2, 121-45. DOI ScienceOn |
7 | Formeister EJ, Tsuchiya M, Fujii H, et al (2010). Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Mutat Res, 692, 26-33. DOI |
8 | Gu C, Lu J, Cui T, et al (2013). Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS One, 8, e7263. |
9 | He J, Qiao JB, Zhu H (2011). p14ARF promoter region methylation as a marker for gliomas diagnosis. Med Oncol, 28, 1218-24. DOI |
10 | Herath NI, Purdie DM, Kew MC, et al (2009). Varying etiologies lead to different molecular changes in Australian and South African hepatocellular carcinomas. Int J Oncol, 35, 1081-9. |
11 | Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. DOI ScienceOn |
12 | Iakova P, Timchenko L, Timchenko NA (2011). Intracellular signaling and hepatocellular carcinoma. Semin Cancer Biol, 21, 28-34. DOI ScienceOn |
13 | Ishikawa T, Zhang SS, Qin X, et al (2004). DNA repair and cancer: lessons from mutant mouse models. Cancer Sci, 95, 112-7. DOI |
14 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
15 | Li B, Liu W, Wang L, et al (2010). CpG island methylator phenotype associated with tumor recurrence in tumor-nodemetastasis stage I hepatocellular carcinoma. Ann Surg Oncol, 17, 1917-26. DOI |
16 | Kim YT, Lee SH, Sung SW, Kim JH (2005). Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection. Ann Thorac Surg, 79, 1180-8. DOI |
17 | Kupcinskaite-Noreikiene R, Skieceviciene J, Jonaitis L, et al (2013). CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues. Medicina, 49, 361-6. |
18 | Laing ME, Cummins R, O'Grady A, et al (2010). Aberrant DNA methylation associated with MTHFR C677T genetic polymorphism in cutaneous squamous cell carcinoma in renal transplant patients. Br J Dermatol, 163, 345-52. DOI |
19 | Li H, Gao B, Yu Z, Liu J, Zhang J (2013). Significance of detection of mutigene methylation in liver cancer tissues for early diagnosis of liver cancer. J Clin Hepatol, 29, 624-6. |
20 | Liu W, Wang L, Wang J, et al (2006). Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma. Ai Zheng, 25, 696-700. |
21 | Lou C, Yang B, Gao Y, et al (2008). Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi, 30, 831-6. |
22 | Luo M, Tang H, Zhou Q, et al (2013). Realizing the meta-analysis of single rate in R software. J Evidence-based Medicine, 13, 181-8. |
23 | Moribe T, Iizuka N, Miura T, et al (2009). Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. Int J Cancer, 125, 388-97. DOI |
24 | Ruan X, Wang S, Chen X, Ren P (2007). 5' CpG methylation of P14ARF gene in hepatocellular carcinoma. Chin J Gen Surg, 22, 848-50. |
25 | Nomoto S, Kinoshita T, Kato K, et al (2007). Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer, 97, 1260-5. DOI ScienceOn |
26 | Pomerantz J, Schreiber-Agus N, Liegeois NJ, et al (1998). The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92, 713-23. DOI ScienceOn |
27 | Qian B, Zhu L, Geng X, et al (2005). Methylation of MGMT, DAPK, THBS1 and RIZ1 genes in hepatocellular carcinoma. Chin J Gen Surg, 20, 291-4. |
28 | Saelee P, Chuensumran U, Wongkham S, et al (2012). Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients. Asian Pac J Cancer Prev, 13, 3489-93. 과학기술학회마을 DOI |
29 | Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25, 603-5. DOI |
30 | Su PF, Lee TC, Lin PJ, et al (2007). Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Int J Cancer, 121, 1257-64. DOI |
31 | Tannapfel A, Busse C, Weinans L, et al (2001). INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene, 20, 7104-9. DOI ScienceOn |
32 | Tian K, Lin L, Jia T, Guo X, Zhang L (2006). Promoter methylation status and protein expression of p14ARF gene in squamous cell carcinoma and adenocarcinoma of the lung. Zhongguo Fei Ai Za Zhi, 9, 40-44. |
33 | Zhang C, Guo X, Zhang L, et al (2008). Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma. J Surg Oncol, 98, 462-8. DOI |
34 | Yang B, Guo M, Herman JG, Clark DP (2003). Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol, 163, 1101-7. DOI ScienceOn |
35 | Yu J, Ni M, Xu J, et al (2002). Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer, 2, 29. DOI |
36 | Yu J, Zhang HY, Ma ZZ, et al (2003). Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Cell Res, 13, 319-33. DOI ScienceOn |
37 | Zhang C, Li Z, Cheng Y, et al (2007). CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Clin Cancer Res, 13, 944-52. DOI |
38 | Zhang JC, Gao B, Yu ZT, et al (2014). Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection. Tumour Biol, 35, 2795-802. DOI |
39 | Zhang Y, Xiong Y, Yarbrough WG (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92, 725-34. DOI ScienceOn |
40 | Egger M, Davey SG, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI ScienceOn |